SC
SOSIN CLIFFORD Dirigeant
Other M
US US · SEC (Form 4)
€135m
▲ Purchases (19 ops.)
Discover the complete record of transactions filed by SOSIN CLIFFORD, Dirigeant. Director active across 2 companies, notably Cardlytics, Inc.. Aggregated, 20 filings have been published. Total volume traded: €135.3m. The latest transaction was disclosed on 9 May 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations 20 total
€608,157 444,375 shares @ €1.3686 3.3% of flow
Common Stock
SEC:0001387131-22-006027:0 · 9 May 2022
€1m 470,000 shares @ €3.188 8.3% of flow
Common Stock
SEC:0001387131-22-004785:0 · 8 Apr 2022
Ideal exit: 3 Jan 2023 (T+270) €967,505 317,500 shares @ €3.0473 5.3% of flow
Common Stock
SEC:0001387131-22-004749:0 · 7 Apr 2022
Ideal exit: 2 Jan 2023 (T+270) €3m 1,162,500 shares @ €2.986 19.1% of flow
Common Stock
SEC:0001387131-22-004689:0 · 6 Apr 2022
Ideal exit: 1 Jan 2023 (T+270) €1m 227,952 shares @ €5.7163 22.4% of flow
Common Stock
SEC:0001387131-22-000172 · 5 Jan 2022
Ideal exit: 2 Oct 2022 (T+270) €3m 56,815 shares @ €55.5904 8.68% mcap 5.4% of flow
Common Stock
SEC:0001387131-22-000171 · 5 Jan 2022
Ideal exit: 2 Oct 2022 (T+270) €1m 227,952 shares @ €5.7163 7.2% of flow
Common Stock
SEC:0001387131-22-000172:0 · 5 Jan 2022
Ideal exit: 2 Oct 2022 (T+270) €3m 56,815 shares @ €55.5904 8.68% mcap 2.7% of flow
Common Stock
SEC:0001387131-22-000171:0 · 5 Jan 2022
Ideal exit: 2 Oct 2022 (T+270) €4m 75,000 shares @ €59.3087 12.22% mcap 7.6% of flow
Common Stock
SEC:0001387131-22-000099 · 3 Jan 2022
Ideal exit: 30 Sept 2022 (T+270) €2m 434,531 shares @ €5.2808 39.5% of flow
Common Stock
SEC:0001387131-22-000098 · 3 Jan 2022
Ideal exit: 30 Sept 2022 (T+270) €4m 75,000 shares @ €59.3087 12.22% mcap 3.8% of flow
Common Stock
SEC:0001387131-22-000099:0 · 3 Jan 2022
Ideal exit: 30 Sept 2022 (T+270) €2m 434,531 shares @ €5.2808 12.6% of flow
Common Stock
SEC:0001387131-22-000098:0 · 3 Jan 2022
Ideal exit: 30 Sept 2022 (T+270) €2m 470,000 shares @ €4.6952 38.0% of flow
Common Stock
SEC:0001387131-21-011786 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) €2m 36,875 shares @ €59.8436 6.06% mcap 3.8% of flow
Common Stock
SEC:0001387131-21-011785 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) €2m 36,875 shares @ €59.8436 6.06% mcap 1.9% of flow
Common Stock
SEC:0001387131-21-011785:0 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) €2m 470,000 shares @ €4.6952 12.2% of flow
Common Stock
SEC:0001387131-21-011786:0 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) €21m 290,000 shares @ €74.1109 59.03% mcap 36.7% of flow
Common Stock
SEC:0001387131-21-008307 · 6 Aug 2021
Ideal exit: 3 May 2022 (T+270) €21m 290,000 shares @ €74.1109 59.03% mcap 18.3% of flow
Common Stock
SEC:0001387131-21-008307:0 · 6 Aug 2021
Ideal exit: 3 May 2022 (T+270) €27m 370,619 shares @ €73.5613 74.88% mcap 46.5% of flow
Common Stock
SEC:0001387131-21-008279 · 5 Aug 2021
Ideal exit: 2 May 2022 (T+270) €27m 370,619 shares @ €73.5613 74.88% mcap 23.3% of flow
Common Stock
SEC:0001387131-21-008279:0 · 5 Aug 2021
Ideal exit: 2 May 2022 (T+270) About SOSIN CLIFFORD Clifford Sosin is a significant shareholder of Cardlytics, Inc.